News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG's MS Pill Gets First Approval in Russia, U.S. and Others May Follow



9/10/2010 7:14:43 AM

ZURICH, Sept 10 (Reuters) - Swiss drugmaker Novartis (NOVN.VX) has won its first approval for multiple sclerosis (MS) tablet Gilenya in Russia, raising hopes of U.S. Food and Drug Administration (FDA) approval later this month.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES